Literature DB >> 25256659

Prevalence and Correlates of Sexual Dysfunction in Men and Women With Type 2 Diabetes.

Anne Rutte1, Maaike M I van Splunter, Amber A W A van der Heijden, Laura M C Welschen, Petra J M Elders, Jacqueline M Dekker, Frank J Snoek, Paul Enzlin, Giel Nijpels.   

Abstract

This study aimed to assess the prevalence and correlates of sexual dysfunction in a sample of Dutch men and women with type 2 diabetes. Patients with type 2 diabetes who were between the ages of 40 and 75 years from 4 Dutch diabetes centers were asked to complete self-report questionnaires covering sociodemographic characteristics, medical characteristics, clinical depression (Center for Epidemiological Studies), and sexual dysfunction (in men: International Index of Erectile Function; in women: Female Sexual Function Index). In total, 158 type 2 diabetes patients (68% men) completed the cross-sectional survey. On the basis of predefined criteria, 69% of men and 70% of women were classified with some degree of sexual dysfunction. Univariable logistic regression analyses revealed that sexual dysfunctions were associated with higher age, clinical depression (Center for Epidemiological Studies score ≥16), and one or more diabetes-related complications in both men and women. Multivariable logistic regression analyses revealed that clinical depression was most strongly associated with both male (OR = 6.87, 95% CI [1.77, 26.63]) and female (OR = 9.33, 95% CI [1.03, 84.87]) sexual dysfunction. In conclusion, sexual dysfunction is highly prevalent in men and women with type 2 diabetes and is associated with higher age, clinical depression, and diabetes-related complications. These results suggest that addressing sexual dysfunction in diabetes care is important.

Entities:  

Mesh:

Year:  2014        PMID: 25256659     DOI: 10.1080/0092623X.2014.966399

Source DB:  PubMed          Journal:  J Sex Marital Ther        ISSN: 0092-623X


  6 in total

1.  The combined polymorphisms of interleukin-6-174GG genotype and interleukin-10 ATA haplotype are associated with a poor quality of life in patients with chronic hepatitis C.

Authors:  Diego Alves Vieira; Luciana Rodrigues da Cunha; Cliviany Borges da Silva; Maria Thereza Bastos Almeida; Adriana Dias Gomes; César Lúcio Lopes de Faria; Rosângela Teixeira; Fernando Silva Neves; Gifone Aguiar Rocha; Fabrício Freire de Melo; Dulciene Maria de Magalhães Queiroz; Luciana Diniz Silva
Journal:  Qual Life Res       Date:  2019-02-07       Impact factor: 4.147

2.  Sexual dysfunction among diabetics and its impact on the SQoL of their partners.

Authors:  W K B A Owiredu; H Alidu; N Amidu; C Obirikorang; C K Gyasi-Sarpong; A T Bawah; P P M Dapare; A T Luuse
Journal:  Int J Impot Res       Date:  2017-08-17       Impact factor: 2.896

3.  Effectiveness of a PLISSIT model intervention in patients with type 2 diabetes mellitus in primary care: design of a cluster-randomised controlled trial.

Authors:  Anne Rutte; Patricia van Oppen; Giel Nijpels; Frank J Snoek; Paul Enzlin; Peter Leusink; Petra J M Elders
Journal:  BMC Fam Pract       Date:  2015-06-02       Impact factor: 2.497

Review 4.  Diabetic Neuropathy: A Position Statement by the American Diabetes Association.

Authors:  Rodica Pop-Busui; Andrew J M Boulton; Eva L Feldman; Vera Bril; Roy Freeman; Rayaz A Malik; Jay M Sosenko; Dan Ziegler
Journal:  Diabetes Care       Date:  2017-01       Impact factor: 19.112

5.  Comorbidity of Mental Disorder in Patients with Chronic Disease: A Comparative Study of Heroin Dependence Patients and Diabetes Mellitus Patients.

Authors:  Tahereh Seghatoleslam; Abolfazl Ardakani; Hussain Habil; Rusid Rashid
Journal:  Iran J Public Health       Date:  2022-01       Impact factor: 1.429

6.  Depression and Mortality in People with Type 2 Diabetes Mellitus, 2003 to 2013: A Nationwide Population-Based Cohort Study.

Authors:  Jong Hyun Jeong; Yoo Hyun Um; Seung Hyun Ko; Jong Heon Park; Joong Yeol Park; Kyungdo Han; Kyung Soo Ko
Journal:  Diabetes Metab J       Date:  2017-08       Impact factor: 5.376

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.